10/17/2025RemeGen's Telitacicept Demonstrates Strong Phase 3 Efficacy in Lupus, ...

10/17/2025Dianthus Secures Exclusive Global Rights to DNTH212 from China's Leads...

10/17/2025Roche Expands Oncology Pipeline Thru Global Licensing Deal with Hansoh...

10/17/2025I-Mab to Rebrand as NovaBridge Biosciences and Pursue Hong Kong IPO

10/16/2025NHC Holds High-Level Meetings with Abbott and Roche to Advance Healthc...

10/16/2025China NMPA Cancels 80 Drug Registration Certificates, Including Lorata...

10/16/2025Belite Bio Secures Priority Review from China's NMPA for Tinlarebant

10/16/2025Kailera Launches with $600M Series B to Advance GLP-1 Portfolio Acqui...

10/16/2025Xuanzhu Bio Soars on Hong Kong Debut After Highly Oversubscribed IPO

10/16/2025Qilu Presents Promising Phase I Data for AR PROTAC Degrader QLH12016

10/15/2025Sino Biopharma's TQB2102 Receives Breakthru Therapeutic Designation in...

10/15/2025Pfizer CEO Calls for Greater U.S.–China Collaboration in Biopharma In...

10/14/2025GSK's Shingrix Wins Chinese Approval for Expanded Use

10/14/2025Biokin and SystImmune Present Promising Early Data for EGFR×HER3 Bisp...

10/14/2025Multitude Reports Updated Safety and Dose Findings for AMT-116 at ESMO...

10/14/2025AskBio Reports Promising Safety Results from First Cohort of AB-1003 G...

10/13/2025Huadao Secures Over CNY 100M in Series D+2 Financing to Advance CAR-T ...

10/13/2025Lepu Reports Early Clinical Data for ADC Programs in Various Cancers

10/13/2025Hansoh Pharma Reports Phase II Data for Oral B7H3 ADC HS-20093

10/13/2025Lundbeck's Epilepsy Drug Bexicaserin Granted Breakthrough Therapy Stat...

10/13/2025Two Decades of Pediatric Drug Trials in China Reveal Progress and Pers...

10/13/2025CDE Seeks Input on Draft Technical Requirements for Sodium Iodide [131...

10/13/2025CDE Solicits Comments on Draft Guidelines for Bioequivalence Risk Asse...

10/13/2025CDE Issues Guidance to Address Common Challenges in Pediatric Drug Dev...

10/13/2025China Introduces New Regulations to Govern Clinical Research and Appli...

10/13/2025AviadoBio and UgeneX Enter Exclusive Option-License Deal to Develop Op...

10/13/2025Huadao Bio Secures Over CNY 100M in Series D+2 Financing

10/13/2025Kelun-Biotech Presents Promising Phase 1 Data for CLDN18.2 ADC SKB315

10/13/2025CF PharmaTech Soars 161% on Hong Kong IPO Debut

10/13/2025Eccogene Files for Hong Kong IPO

Page:20/60 Total number of articles:1794: [First][<<] [18] [19] [20] [21] [22] [>>] [End]